IGF1 and Hyperinsulinemia: Additionally, hyperinsulinemia increases hepatic growth hormone receptor (GHR) levels and down-regulates the level of IGF-binding protein 1, raising the bioavailablility of IGF-1 on cellular proliferation and inhibition of apoptosis37, 38.